Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience

by Jacqueline M. Miller, Narcisa Mesaros, Marie Van Der Wielen, Yaela Baine
Published 2011-01-01

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

by Charissa Fay Corazon Borja-Tabora, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Veronique Bianco, Emmanuel Aris, Mark Cutler, Ping Li, John L. Perez
Published 2020-06-01